PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.\', \'Ophthalmology, MIOS, Lausanne, Switzerland.\', \'Ophthalmology, University of Washington, Seattle, Washington, USA.\', \'Department of Ophthalmology, Postgraduate Institute of Medical Education and Research, Advanced Eye Centre, Chandigarh, India.\', \'College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.\', \'Department of Medical Retina and Uveitis, Sydney Eye Hospital, Sydney, New South Wales, Australia.\', \'Save Sight Institute, Sydney, New South Wales, Australia.\', \'Divsion of Ocular Immunology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA.\', \'Department of Ophthalmology, Massachusetts Eye and Ear and Harvard Medical School, Boston, Massachusetts, USA.\', \'MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital and Myung Sung Medical College, Addis Ababa, Ethiopia.\', \'University of Tuebingen, Tubingen, Germany.\', \'Byers Eye Institute, Stanford University, Palo Alto, California, USA.\', \'Department of Medical Retina and Uveitis, Moorfields Eye Hospital NHS Foundation Trust, London, London, UK.\', \'Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore rupesh_agrawal@ttsh.com.sg.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bjophthalmol-2020-316586
?:hasPublicationType
?:journal
  • The British journal of ophthalmology
is ?:pmid of
?:pmid
?:pmid
  • 32532764
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all